1. Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
2. Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;
3. Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
4. Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
5. Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY;
6. Department of Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
7. Division of Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;
8. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;
9. Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;
10. Ateneo Vita-Salute and Unit of Lymphoid Malignancies, San Raffaele H. Scientific Institute, Milan, Italy;
11. Department of Medical Sciences, University of Torino and Immunogenetics Unit, Human Genetics Foundation, Torino, Italy;
12. Division of Pathology, Department of Health Sciences, Amedeo Avogadro University of Eastern Piedmont and Maggiore Hospital, Novara, Italy;
13. Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy;
14. Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; and
15. Department of Pathology, NYU Cancer Center, New York University School of Medicine, New York, NY